Found: 106
Select item for more details and to access through your institution.
Age-Associated Seroprevalence of Coronavirus Antibodies: Population-Based Serosurveys in 2013 and 2020, British Columbia, Canada.
- Published in:
- Frontiers in Immunology, 2022, v. 13, p. 1, doi. 10.3389/fimmu.2022.836449
- By:
- Publication type:
- Article
Previous infection with seasonal coronaviruses does not protect male Syrian hamsters from challenge with SARS-CoV-2.
- Published in:
- Nature Communications, 2023, v. 14, n. 1, p. 1, doi. 10.1038/s41467-023-41761-1
- By:
- Publication type:
- Article
Influenza Hospitalization Burden by Subtype, Age, Comorbidity, and Vaccination Status: 2012–2013 to 2018–2019 Seasons, Quebec, Canada.
- Published in:
- Clinical Infectious Diseases, 2024, v. 78, n. 3, p. 765, doi. 10.1093/cid/ciad627
- By:
- Publication type:
- Article
Single-dose Effectiveness of Mpox Vaccine in Quebec, Canada: Test-negative Design With and Without Adjustment for Self-reported Exposure Risk.
- Published in:
- Clinical Infectious Diseases, 2024, v. 78, n. 2, p. 461, doi. 10.1093/cid/ciad584
- By:
- Publication type:
- Article
Single-Dose Messenger RNA Vaccine Effectiveness Against Severe Acute Respiratory Syndrome Coronavirus 2 in Healthcare Workers Extending 16 Weeks Postvaccination: A Test-Negative Design From Québec, Canada.
- Published in:
- Clinical Infectious Diseases, 2022, v. 75, n. 1, p. e805, doi. 10.1093/cid/ciab739
- By:
- Publication type:
- Article
Single-dose mRNA Vaccine Effectiveness Against Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2), Including Alpha and Gamma Variants: A Test-negative Design in Adults 70 Years and Older in British Columbia, Canada.
- Published in:
- Clinical Infectious Diseases, 2022, v. 74, n. 7, p. 1158, doi. 10.1093/cid/ciab616
- By:
- Publication type:
- Article
Comparative Immunogenicity of Several Enhanced Influenza Vaccine Options for Older Adults: A Randomized, Controlled Trial.
- Published in:
- Clinical Infectious Diseases, 2020, v. 71, n. 7, p. 1704, doi. 10.1093/cid/ciz1034
- By:
- Publication type:
- Article
Evidence in a Cluster Randomized Controlled Trial of Increased 2009 Pandemic Risk Associated With 2008–2009 Seasonal Influenza Vaccine Receipt.
- Published in:
- 2019
- By:
- Publication type:
- Letter to the Editor
Caution Required in the Use of Administrative Data and General Laboratory Submissions for Influenza Vaccine Effectiveness Estimation.
- Published in:
- Clinical Infectious Diseases, 2019, v. 69, n. 6, p. 1084, doi. 10.1093/cid/ciz113
- By:
- Publication type:
- Article
Vaccine Effectiveness Against Lineage-matched and -mismatched Influenza B Viruses Across 8 Seasons in Canada, 2010–2011 to 2017–2018.
- Published in:
- Clinical Infectious Diseases, 2019, v. 68, n. 10, p. 1754, doi. 10.1093/cid/ciy876
- By:
- Publication type:
- Article
Role of Egg-adaptation Mutations in Low Influenza A(H3N2) Vaccine Effectiveness During the 2012–2013 Season.
- Published in:
- 2018
- By:
- Publication type:
- Letter to the Editor
Ecological Fallacy, Nonspecific Outcomes, and the Attribution of Disproportionate Vaccine Benefits.
- Published in:
- 2018
- By:
- Publication type:
- Letter to the Editor
Influenza A(H3N2) Antibody Responses to Standard-Dose Versus Enhanced Influenza Vaccine Immunogenicity in Older Adults and Prior Season's Vaccine Status.
- Published in:
- Journal of Infectious Diseases, 2024, v. 229, n. 5, p. 1451, doi. 10.1093/infdis/jiad497
- By:
- Publication type:
- Article
BNT162b2 Effectiveness Against Delta and Omicron Variants of Severe Acute Respiratory Syndrome Coronavirus 2 in Adolescents Aged 12–17 Years, by Dosing Interval and Duration.
- Published in:
- Journal of Infectious Diseases, 2023, v. 227, n. 9, p. 1073, doi. 10.1093/infdis/jiad006
- By:
- Publication type:
- Article
Comparative Single-Dose mRNA and ChAdOx1 Vaccine Effectiveness Against Severe Acute Respiratory Syndrome Coronavirus 2, Including Variants of Concern: Test-Negative Design, British Columbia, Canada.
- Published in:
- Journal of Infectious Diseases, 2022, v. 226, n. 3, p. 485, doi. 10.1093/infdis/jiac023
- By:
- Publication type:
- Article
Comparative Single-Dose mRNA and ChAdOx1 Vaccine Effectiveness Against Severe Acute Respiratory Syndrome Coronavirus 2, Including Variants of Concern: Test-Negative Design, British Columbia, Canada.
- Published in:
- Journal of Infectious Diseases, 2022, v. 226, n. 1, p. 11, doi. 10.1093/infdis/jiac023
- By:
- Publication type:
- Article
Influenza Vaccine Effectiveness by A(H3N2) Phylogenetic Subcluster and Prior Vaccination History: 2016-2017 and 2017-2018 Epidemics in Canada.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Avian Influenza A(H7N9) Virus Infection in 2 Travelers Returning from China to Canada, January 2015.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Seroconversion to seasonal influenza viruses after A(H1N1)pdm09 virus infection, Quebec, Canada.
- Published in:
- 2012
- By:
- Publication type:
- journal article
Seroconversion to Seasonal Influenza Viruses after A(H1N1) pdm09 Virus Infection, Quebec, Canada.
- Published in:
- Emerging Infectious Diseases, 2012, v. 18, n. 7, p. 1132, doi. 10.3201/eid1807.111680
- By:
- Publication type:
- Article
Coordinated Response to SARS, Vancouver, Canada.
- Published in:
- Emerging Infectious Diseases, 2006, v. 12, n. 1, p. 155, doi. 10.3201/eid1201.050327
- By:
- Publication type:
- Article
Modeling Control Strategies of Respiratory Pathogens.
- Published in:
- Emerging Infectious Diseases, 2005, v. 11, n. 8, p. 1249, doi. 10.3201/eid1108.040449
- By:
- Publication type:
- Article
Human Illness from Avian Influenza H7N3, British Columbia.
- Published in:
- Emerging Infectious Diseases, 2004, v. 10, n. 12, p. 2196, doi. 10.3201/eid1012.040961
- By:
- Publication type:
- Article
Novel Avian Influenza H7N3 Strain Outbreak, British Columbia.
- Published in:
- Emerging Infectious Diseases, 2004, v. 10, n. 12, p. 2192, doi. 10.3201/eid1012.040743
- By:
- Publication type:
- Article
Reduced Antibody Response to Infant Measles Vaccination: Effects Based on Type and Timing of the First Vaccine Dose Persist After the Second Dose.
- Published in:
- Clinical Infectious Diseases, 2017, v. 65, n. 7, p. 1094, doi. 10.1093/cid/cix510
- By:
- Publication type:
- Article
Pooling and the Potential Dilution of Repeat Influenza Vaccination Effects.
- Published in:
- 2017
- By:
- Publication type:
- Letter to the Editor
Repeat Influenza Vaccination and High-Dose Efficacy.
- Published in:
- 2016
- By:
- Publication type:
- Letter to the Editor
A Perfect Storm: Impact of Genomic Variation and Serial Vaccination on Low Influenza Vaccine Effectiveness During the 2014-2015 Season.
- Published in:
- Clinical Infectious Diseases, 2016, v. 63, n. 1, p. 21, doi. 10.1093/cid/ciw176
- By:
- Publication type:
- Article
Understanding Suboptimal Influenza Vaccine Effectiveness Within the Agent, Host, and Environment Paradigm.
- Published in:
- 2013
- By:
- Publication type:
- Letter
A Sentinel Platform to Evaluate Influenza Vaccine Effectiveness and New Variant Circulation, Canada 2010–2011 Season.
- Published in:
- Clinical Infectious Diseases, 2012, v. 55, n. 3, p. 332, doi. 10.1093/cid/cis431
- By:
- Publication type:
- Article
Higher Risk of Measles When the First Dose of a 2-Dose Schedule of Measles Vaccine Is Given at 12–14 Months Versus 15 Months of Age.
- Published in:
- Clinical Infectious Diseases, 2012, v. 55, n. 3, p. 394, doi. 10.1093/cid/cis439
- By:
- Publication type:
- Article
The Number Needed to Vaccinate to Prevent Infant Pertussis Hospitalization and Death Through Parent Cocoon Immunization.
- Published in:
- Clinical Infectious Diseases, 2012, v. 54, n. 3, p. 318, doi. 10.1093/cid/cir836
- By:
- Publication type:
- Article
Mechanism for Seasonal Vaccine Effect on Pandemic H1N1 Risk Remains Uncertain.
- Published in:
- 2011
- By:
- Publication type:
- Letter
Seasonal Influenza Vaccine and Increased Risk of Pandemic A/H1N1-Related Illness: First Detection of the Association in British Columbia, Canada.
- Published in:
- Clinical Infectious Diseases, 2010, v. 51, n. 9, p. 1017, doi. 10.1086/656586
- By:
- Publication type:
- Article
Bats in the Bedroom, Bats in the Belfry: Reanalysis of the Rationale for Rabies Postexposure Prophylaxis.
- Published in:
- Clinical Infectious Diseases, 2009, v. 48, n. 11, p. 1493, doi. 10.1086/598998
- By:
- Publication type:
- Article
Protective measures and human antibody response during an avian influenza H<sub>7</sub>N<sub>3</sub> outbreak in poultry in British Columbia, Canada.
- Published in:
- CMAJ: Canadian Medical Association Journal Supplement, 2007, v. 176, n. 1, p. 47, doi. 10.1503/cmaj.060204
- By:
- Publication type:
- Article
Physical, Psychological, and Cognitive Profile of Post-COVID Conditions in Healthcare Workers, Quebec, Canada.
- Published in:
- Open Forum Infectious Diseases, 2022, v. 9, n. 8, p. 1, doi. 10.1093/ofid/ofac386
- By:
- Publication type:
- Article
SARS-CoV-2 mRNA Vaccine Effectiveness in Health Care Workers by Dosing Interval and Time Since Vaccination: Test-Negative Design, British Columbia, Canada.
- Published in:
- Open Forum Infectious Diseases, 2022, v. 9, n. 5, p. 1, doi. 10.1093/ofid/ofac178
- By:
- Publication type:
- Article
Should Sex Be Considered an Effect Modifier in the Evaluation of Influenza Vaccine Effectiveness?
- Published in:
- Open Forum Infectious Diseases, 2018, v. 5, n. 9, p. N.PAG, doi. 10.1093/ofid/ofy211
- By:
- Publication type:
- Article
Other Respiratory Viruses Are Important Contributors to Adult Respiratory Hospitalizations and Mortality Even During Peak Weeks of the Influenza Season.
- Published in:
- Open Forum Infectious Diseases, 2014, v. 1, n. 2, p. 1, doi. 10.1093/ofid/ofu086
- By:
- Publication type:
- Article
Influenza vaccine effectiveness against A(H3N2) during the delayed 2021/22 epidemic in Canada.
- Published in:
- Eurosurveillance (15607917), 2022, v. 27, n. 38, p. 2, doi. 10.2807/1560-7917.ES.2022.27.38.2200720
- By:
- Publication type:
- Article
Interim estimates of 2019/20 vaccine effectiveness during early-season co-circulation of influenza A and B viruses, Canada, February 2020.
- Published in:
- Eurosurveillance (15607917), 2020, v. 25, n. 7, p. 2, doi. 10.2807/1560-7917.es.2020.25.7.2000103
- By:
- Publication type:
- Article
Paradoxical clade- and age-specific vaccine effectiveness during the 2018/19 influenza A(H3N2) epidemic in Canada: potential imprint-regulated effect of vaccine (I-REV).
- Published in:
- Eurosurveillance (15607917), 2019, v. 24, n. 46, p. 1, doi. 10.2807/1560-7917.ES.2019.24.46.1900585
- By:
- Publication type:
- Article
Children under 10 years of age were more affected by the 2018/19 influenza A(H1N1)pdm09 epidemic in Canada: possible cohort effect following the 2009 influenza pandemic.
- Published in:
- Eurosurveillance (15607917), 2019, v. 24, n. 15, p. 32, doi. 10.2807/1560-7917.ES.2019.24.15.1900104
- By:
- Publication type:
- Article
Interim estimates of 2018/19 vaccine effectiveness against influenza A(H1N1)pdm09, Canada, January 2019.
- Published in:
- Eurosurveillance (15607917), 2019, v. 24, n. 4, p. 6, doi. 10.2807/1560-7917.ES.2019.24.4.1900055
- By:
- Publication type:
- Article
Early season co-circulation of influenza A(H3N2) and B(Yamagata): interim estimates of 2017/18 vaccine effectiveness, Canada, January 2018.
- Published in:
- Eurosurveillance (15607917), 2018, v. 23, n. 5, p. 2, doi. 10.2807/1560-7917.ES.2018.23.5.18-00035
- By:
- Publication type:
- Article
Low 2012–13 Influenza Vaccine Effectiveness Associated with Mutation in the Egg-Adapted H3N2 Vaccine Strain Not Antigenic Drift in Circulating Viruses.
- Published in:
- PLoS ONE, 2014, v. 9, n. 3, p. 1, doi. 10.1371/journal.pone.0092153
- By:
- Publication type:
- Article
Randomized Controlled Ferret Study to Assess the Direct Impact of 2008–09 Trivalent Inactivated Influenza Vaccine on A(H1N1)pdm09 Disease Risk.
- Published in:
- PLoS ONE, 2014, v. 9, n. 1, p. 1, doi. 10.1371/journal.pone.0086555
- By:
- Publication type:
- Article
H3N2v and Other Influenza Epidemic Risk Based on Age- Specific Estimates of Sero-Protection and Contact Network Interactions.
- Published in:
- PLoS ONE, 2013, v. 8, n. 1, p. 1, doi. 10.1371/journal.pone.0054015
- By:
- Publication type:
- Article
Cross-Lineage Influenza B and Heterologous Influenza AAntibody Responses in Vaccinated Mice: ImmunologicInteractions and B/Yamagata Dominance.
- Published in:
- PLoS ONE, 2012, v. 7, n. 6, p. 1, doi. 10.1371/journal.pone.0038929
- By:
- Publication type:
- Article